{
    "2021-03-27": [
        [
            {
                "time": "",
                "original_text": "复星医药：复宏汉霖就BRAF V600E抑制剂与润新生物签订许可协议",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "BRAF V600E抑制剂",
                        "润新生物",
                        "许可协议"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "「财富周评榜」“医茅们”表现分化：迈瑞医疗市值涨304亿，“女人的茅台”爱美客周跌超13%",
                "features": {
                    "keywords": [
                        "财富周评榜",
                        "医茅",
                        "迈瑞医疗",
                        "市值涨",
                        "爱美客",
                        "周跌"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "科创板蓄势待发，中国生物制药2020处于业绩过渡期",
                "features": {
                    "keywords": [
                        "科创板",
                        "中国生物制药",
                        "业绩过渡期"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}